Plexus (NASDAQ:PLXS) Posts Earnings Results, Beats Estimates By $0.29 EPS

Plexus (NASDAQ:PLXS – Get Free Report) issued its earnings results on Wednesday. The technology company reported $2.84 earnings per share for the quarter, topping analysts’ consensus estimates of $2.55 by $0.29, Briefing.com reports. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.36 billion. Plexus had a net margin of 4.08% and a return on equity of 13.50%. Plexus’s revenue for the quarter was up 34.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.14 earnings per share.

Plexus Stock Performance

Shares of PLXS stock opened at $212.56 on Friday. The firm has a market capitalization of $5.69 billion, a price-to-earnings ratio of 28.64 and a beta of 0.88. Plexus has a 1 year low of $132.03 and a 1 year high of $307.06. The business has a fifty day moving average of $247.43 and a 200 day moving average of $239.20. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72.

Wall Street Analyst Weigh In

PLXS has been the topic of a number of recent research reports. Needham & Company LLC restated a “buy” rating and set a $310.00 price objective on shares of Plexus in a research report on Friday, August 14th. Weiss Ratings downgraded Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 23rd. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. KeyCorp raised shares of Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price objective for the company in a research note on Monday, September 21st. Finally, Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective on the stock in a research report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $276.86.

Get Our Latest Report on Plexus

Insiders Place Their Bets

In other news, Director Karen Rapp sold 500 shares of Plexus stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $240.87, for a total transaction of $120,435.00. Following the completion of the transaction, the director directly owned 7,535 shares of the company’s stock, valued at $1,814,955.45. The trade was a 6.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd Kelsey sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 21st. The shares were sold at an average price of $239.16, for a total value of $358,740.00. Following the completion of the sale, the chief executive officer directly owned 62,888 shares in the company, valued at approximately $15,040,294.08. The trade was a 2.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 9,000 shares of company stock worth $2,319,260. Corporate insiders own 1.78% of the company’s stock.

Plexus News Summary

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Quarterly results exceeded expectations. Plexus reported fiscal Q4 revenue of $1.427 billion, up 34.9% year over year, and adjusted EPS of $2.84 versus the roughly $2.55–$2.57 consensus. GAAP diluted EPS was $2.51, while adjusted operating margin reached 6.7%. Plexus fiscal fourth-quarter results
  • Positive Sentiment: Growth momentum remains strong. Fiscal 2026 revenue reached a record $4.965 billion, up 23% year over year. Plexus won 36 manufacturing programs representing $290 million in potential annualized revenue at full ramp, and its qualified opportunity funnel expanded 33% to $4.9 billion.
  • Positive Sentiment: First-quarter guidance was above consensus on adjusted earnings. Plexus projected fiscal Q1 2027 adjusted EPS of $2.46–$2.62, above the $2.34 analyst estimate, and revenue of approximately $1.41–$1.46 billion, broadly in line with expectations. Management also raised its long-term non-GAAP operating-margin goal to 6.5%–7.0% and expects mid- to high-teens revenue growth in fiscal 2027.
  • Positive Sentiment: Shareholder returns could provide support. The company authorized a new $100 million fiscal 2027 share-repurchase program after buying back $85 million of stock in fiscal 2026. Management also expects at least $100 million of free cash flow in fiscal 2027.
  • Neutral Sentiment: Technical sentiment has weakened after the stock fell below its 50-day and 200-day moving averages, although an earlier report noted PLXS had crossed above the 200-day average. Analysts cited in the provided coverage maintain targets well above the current trading level.
  • Negative Sentiment: Cash generation and customer concentration remain risks. Fiscal-year free cash flow was negative $28.9 million because of heavy investment and working-capital needs, while the top 10 customers accounted for 56% of fourth-quarter revenue.
  • Negative Sentiment: Insider selling may weigh on sentiment. Reported insider activity showed 26 sales and no purchases over the past six months, including substantial sales by CEO Todd Kelsey.

Plexus Company Profile

(Get Free Report)

Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.

Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.

Featured Articles

Earnings History for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.